Past EventJanuary 28, 2014 – AdvaMed Presentation on Current National Industry Trends

Our January meeting will feature Ashley Wallin, Executive Director and Vice-President of the Emerging Growth Company Council of The Advanced Medical Technology Council (AdvaMed). 

From a broad industry perspective, the current environment is quite possibly the most challenging companies have ever experienced – especially small companies. These smaller companies are the lifeblood of the medical technology industry, with approximately three-quarters of U.S. medtech firms having fewer than 20 employees. These engines of innovation rely on private investment to survive in their critical early stages of growth. Unfortunately, in recent years, access to these funds has declined significantly.

During this meeting, we will discuss current national and international trends in the industry, including where companies are currently accessing capital and new policies affecting your businesses the most in diagnostics, therapeutics, research, joint development or partnership agreements, markets, acquisitions, and other hot topics.  We will also discuss what we in New Mexico should be advocating for in public policies in order to grow our own robust industry.

Our Speaker: Ashley Wallin is the Executive Director and Vice President for AdvaMed’s Emerging Growth Company Council (EGCC). In this role, she represents the interests of the Association’s emerging and early-growth enterprises and focuses on facilitating a policy environment conducive to capital formation and innovation, advocating for domestic and international payment and regulatory policies that are favorable to emerging companies, and providing educational opportunities for industry leaders and professionals in this entrepreneurial sector.and pharmaceutical industries with a focus on product development, commercialization strategy, and operations – working with both small, venture-backed enterprises and large corporations, including Eli Lilly and Medtronic.

Wallin received a master’s degree in bioengineering and a bachelor’s degree in mechanical engineering from the Georgia Institute of Technology, and a Master of Business Administration from the University of Virginia’s Darden School of Business..

 The Advanced Medical Technology Association (AdvaMed), is a trade association that leads the effort to advance medical technology in order to achieve healthier lives and healthier economies around the world. AdvaMed represents 80 percent of medical technology firms in the United States and acts as the common voice for companies producing medical devices, diagnostic products and health information systems.

 Medical technology innovators are committed to providing physicians the best tools to diagnose and treat patients. This commitment drives over 7,000 companies in the U.S. to create medical miracles everyday – leading to an 80% increase in patents for breakthrough medical technologies in the last decade. NMBio counts a number of these companies in New Mexico as members and our goal is to help all our biotech businesses succeed.